Boostrix Polio Dosage/Direction for Use

Posology: A single 0.5 ml dose of the vaccine is recommended.
Boostrix Polio may be administered from the age of three years onwards.
Boostrix Polio contains reduced content of diphtheria, tetanus and pertussis antigens in combination with poliomyelitis antigens. Therefore, Boostrix Polio should be administered in accordance with official recommendations and/or local practice.
Boostrix Polio can be administered to pregnant women during the second or the third trimester in accordance with official recommendations (see Indications/Uses, Use in Pregnancy & Lactation and Pharmacology: Pharmacodynamics under Actions).
Boostrix Polio may also be administered to adolescents and adults with unknown vaccination status or incomplete vaccination against diphtheria, tetanus and pertussis as part of an immunisation series against diphtheria, tetanus, pertussis and poliomyelitis. Based on data in adults, two additional doses of a diphtheria and tetanus containing vaccine are recommended one and six months after the first dose to maximize the vaccine response against diphtheria and tetanus (see Pharmacology: Pharmacodynamics under Actions).
Boostrix Polio can be used in the management of tetanus prone injuries in persons who have previously received a primary vaccination series of tetanus toxoid vaccine and for whom a booster against diphtheria, pertussis and poliomyelitis is indicated. Tetanus immunoglobulin should be administered concomitantly in accordance with official recommendations.
Repeat vaccination against diphtheria, tetanus, pertussis and poliomyelitis should be performed at intervals as per official recommendations.
Paediatric population: The safety and efficacy of Boostrix Polio in children below 3 years of age have not been established.
Method of administration: Boostrix Polio is for deep intramuscular injection preferably in the deltoid region (see Precautions).